MARKET

SYNH

SYNH

SYNEOS HEALTH
NASDAQ

Real-time Quotes | Nasdaq Last Sale

51.69
-0.39
-0.75%
After Hours: 51.69 0 0.00% 17:51 11/21 EST
OPEN
52.43
PREV CLOSE
52.08
HIGH
52.43
LOW
51.34
VOLUME
352.63K
TURNOVER
--
52 WEEK HIGH
56.34
52 WEEK LOW
36.27
MARKET CAP
5.37B
P/E (TTM)
65.57
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SYNH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SYNH News

  • Syneos Health (SYNH) Presents At Jefferies Global Healthcare Conference - Slideshow
  • Seeking Alpha - Article.7h ago
  • Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
  • GlobeNewswire.11h ago
  • Is Syneos Health (SYNH) a Great Value Stock Right Now?
  • Zacks.1d ago
  • Syneos Health Collaborates with AiCure for Patient Engagement
  • Zacks.11/13 20:39

More

Industry

Biotechnology & Medical Research
-0.31%
Pharmaceuticals & Medical Research
+0.32%

Hot Stocks

Name
Price
%Change

About SYNH

Syneos Health, Inc., formerly INC Research Holdings, Inc., is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
More

Webull offers Syneos Health Inc (SYNH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.